The Pharmacovigilance Department’s objective is to ensure the health of the general public; it monitors, records, evaluates and reports the side-effects of pharmaceuticals already released to the market as well as those tested in clinical trials before their approval, as dictated by European legislation, both to the National Organization for Medicines and to the European Organization for Medicines